We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$78.2B
AUM Growth
+$2.39B
Cap. Flow
-$717M
Cap. Flow %
-0.92%
Top 10 Hldgs %
15.71%
Holding
3,211
New
31
Increased
1,010
Reduced
695
Closed
110

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$200M
2
BKR icon
Baker Hughes
BKR
+$34.7M
3
AMZN icon
Amazon
AMZN
+$30.2M
4
NVDA icon
NVIDIA
NVDA
+$27.1M
5
V icon
Visa
V
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 16.8%
2 Financials 16.62%
3 Healthcare 14.39%
4 Industrials 10.83%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2976
Ocular Therapeutix
OCUL
$2.02B
$115K ﹤0.01%
18,600
AREX
2977
DELISTED
Approach Resources Inc.
AREX
$115K ﹤0.01%
45,800
MSL
2978
DELISTED
Midsouth Bancorp, Inc.
MSL
$114K ﹤0.01%
9,500
JONE
2979
DELISTED
Jones Energy, Inc.
JONE
$114K ﹤0.01%
2,980
-61,981
-95% -$1.65M
BBGI icon
2980
Beasley Broadcasting Group
BBGI
$40M
$113K ﹤0.01%
485
-50
-9% -$10.4K
FGBI icon
2981
First Guaranty Bancshares
FGBI
$159M
$113K ﹤0.01%
5,590
UEC icon
2982
Uranium Energy
UEC
$5.57B
$113K ﹤0.01%
81,900
NVLN
2983
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$113K ﹤0.01%
16,100
FBRX icon
2984
Forte Biosciences
FBRX
$1.57B
$112K ﹤0.01%
24
SNDX icon
2985
Syndax Pharmaceuticals
SNDX
$1.82B
$110K ﹤0.01%
9,400
GNTY
2986
DELISTED
Guaranty Bancshares
GNTY
$109K ﹤0.01%
3,740
RYZ
2987
Ryerson Holding Corp
RYZ
$1.46B
$109K ﹤0.01%
10,000
-60,299
-86% -$531K
TCI icon
2988
Transcontinental Realty Investors
TCI
$318M
$109K ﹤0.01%
4,000
GWRS icon
2989
Global Water Resources
GWRS
$219M
$108K ﹤0.01%
11,500
TUSK icon
2990
Mammoth Energy Services
TUSK
$163M
$108K ﹤0.01%
6,400
XONE
2991
DELISTED
The ExOne Company
XONE
$108K ﹤0.01%
9,500
MVIS icon
2992
Microvision
MVIS
$78.9M
$107K ﹤0.01%
2,560
+667
+35% +$24.1K
ESXB
2993
DELISTED
Community Bankers Trust Corporation
ESXB
$107K ﹤0.01%
11,600
+1,000
+9% +$8.58K
IBRX icon
2994
ImmunityBio
IBRX
$8.1B
$106K ﹤0.01%
19,400
PROV icon
2995
Provident Financial
PROV
$112M
$106K ﹤0.01%
5,400
AQMS icon
2996
Aqua Metals
AQMS
$10.2M
$105K ﹤0.01%
77
-20
-21% -$36K
OFED
2997
DELISTED
Oconee Federal Financial Corp.
OFED
$104K ﹤0.01%
3,700
IMH
2998
DELISTED
Impac Mortgage Holdings Inc.
IMH
$103K ﹤0.01%
7,900
EVI icon
2999
EVI Industries
EVI
$180M
$102K ﹤0.01%
3,700
ZYNE
3000
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$102K ﹤0.01%
12,200

Similar funds

New York State Common Retirement Fund's Q3 2017 Portfolio in Review

As of Q3 2017, New York State Common Retirement Fund held 3,211 positions worth $78.2B, up 3.1% from $75.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 4.4%. New York State Common Retirement Fund opened 31 new positions and exited 110, leaving the 3,211-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • New York State Common Retirement Fund's largest Q3 2017 buy was Baker Hughes: 978,100 shares worth $35.8M.
  • New York State Common Retirement Fund added most to DuPont de Nemours in Q3 2017, an estimated $200M increase.
  • New York State Common Retirement Fund's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $31.6M.
  • New York State Common Retirement Fund fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $185M.
  • New York State Common Retirement Fund's ten largest holdings make up 16% of its $78.2B portfolio in Q3 2017.
  • New York State Common Retirement Fund opened 31 new positions and closed 110 in Q3 2017.
  • New York State Common Retirement Fund's portfolio value rose 3.1% quarter-over-quarter to $78.2B.

Based on New York State Common Retirement Fund's 13F filing for Q3 2017, filed 6 Nov 2017.